QurAlis Revenue and Competitors
Estimated Revenue & Valuation
- QurAlis's estimated annual revenue is currently $15.7M per year.
- QurAlis's estimated revenue per employee is $155,000
Employee Data
- QurAlis has 101 Employees.
- QurAlis grew their employee count by -6% last year.
QurAlis's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder and CEO QurAlis | Reveal Email/Phone |
2 | VP Clinical Operations | Reveal Email/Phone |
3 | VP Regulatory Affairs | Reveal Email/Phone |
4 | SVP, Tralational Science & Portfolio Strategy | Reveal Email/Phone |
5 | Head Discovery, Senior Director | Reveal Email/Phone |
6 | Chief Technology Officer | Reveal Email/Phone |
7 | Chief Business Officer | Reveal Email/Phone |
8 | Clinical Scientist - Director, Clinical Development | Reveal Email/Phone |
9 | Chief Financial Officer | Reveal Email/Phone |
10 | Chief Scientific Officer | Reveal Email/Phone |
QurAlis Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is QurAlis?
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. We are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus our programs on tackling specific disease-causing mechanisms.
keywords:N/A
N/A
Total Funding
101
Number of Employees
$15.7M
Revenue (est)
-6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
QurAlis News
2022-04-13 - 2022 Henri Termeer Transatlantic Connections Award Honorees Announced by
Termeer Foundation as Part of Program Supporting Emerging Life Science
Leaders in the Netherlands and Massachusetts
Kasper Roet, of QurAlis Corporation and Koenraad Wiedhaup, of Leyden Labs presented with annual award at Innovation for Health conference in...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $22M | 101 | 1% | $478.3M |
#2 | $15.7M | 101 | -16% | $380.7M |
#3 | $15.7M | 101 | 63% | $203M |
#4 | $14.6M | 101 | 6% | $28.8M |
#5 | $23.9M | 102 | -3% | N/A |